Xeris Pharmaceuticals, Inc.

Xeris Pharmaceuticals, an American biopharmaceutical company, develops a robust pipeline of programs for extending currently marketed products into new indications and uses while launching new products utilizing proprietary formulation technology platforms; it is headquartered in Wilmington, United States.

Here are key aspects of the company:

• Products & Services: The company has developed a pipeline that extends currently marketed products into important new indications and uses.
• Innovation: Xeris utilizes its proprietary formulation technology platforms to support long-term product development and commercial success.
• Operations: The organization manages development programs designed to launch new products alongside extensions of existing ones.

Xeris Pharmaceuticals leverages its specialized technology platforms to drive the growth and longevity of its therapeutic offerings through strategic pipeline expansion.